HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dexamphetamine improves upper extremity outcome during rehabilitation after stroke: a pilot randomized controlled trial.

AbstractBACKGROUND:
For early inpatient stroke rehabilitation, the effectiveness of amphetamine combined with physiotherapy varies across studies.
OBJECTIVE:
To investigate whether the recovery of activities of daily living (ADL, primary outcome) and motor function (secondary outcome) can be improved by dexamphetamine added to physiotherapy.
METHODS:
In a double-blind, placebo-controlled trial, 16 patients, from 918 who were screened, were randomized to the experimental group (EG, dexamphetamine + physiotherapy) or control group (CG, placebo + physiotherapy). Both groups received multidisciplinary inpatient rehabilitation. Dexamphetamine (10 mg oral) or placebo was administered 2 days per week before physiotherapy. ADL and motor function were measured using the Chedoke-McMaster Stroke Assessment (CMSA) twice during baseline, every week during the 5-week treatment period, and at follow-up 1 week, 6 months, and 12 months after intervention.
RESULTS:
The majority of ineligible patients had too little paresis, were on anticoagulants, or had a stroke >60 days prior to entry. Participants (EG, n = 7, age 70.3 ± 10 years, 5 women, 37.9 ± 9 days after stroke; CG, n = 9, age 65.2 ± 17 years, 3 women, 40.3 ± 9 days after stroke) did not differ at baseline except for the leg subscale. Analysis of variance from baseline to 1 week follow-up revealed significant improvements in favor of EG for subscales ADL (P = .023) and arm function (P = .020) at end of treatment. No adverse events were detected.
CONCLUSION:
In this small trial that was based on prior positive trials, significant gains in ADL and arm function suggest that the dose and timing of dexamphetamine can augment physiotherapy. Effect size calculation suggests inclusion of at least 25 patients per group in future studies.
AuthorsCorina Schuster, Gerd Maunz, Karin Lutz, Udo Kischka, Rolf Sturzenegger, Thierry Ettlin
JournalNeurorehabilitation and neural repair (Neurorehabil Neural Repair) Vol. 25 Issue 8 Pg. 749-55 (Oct 2011) ISSN: 1552-6844 [Electronic] United States
PMID21712481 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Central Nervous System Stimulants
  • Dextroamphetamine
Topics
  • Activities of Daily Living
  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Central Nervous System Stimulants (therapeutic use)
  • Dextroamphetamine (therapeutic use)
  • Double-Blind Method
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Physical Therapy Modalities
  • Pilot Projects
  • Recovery of Function (drug effects, physiology)
  • Stroke (drug therapy)
  • Stroke Rehabilitation
  • Time Factors
  • Treatment Outcome
  • Upper Extremity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: